SCHEMBL31069727

SCHEMBL31069727

O=C1c2cc(Br)cnc2SCCN1Cc1cc(OC(F)(F)F)ccc1F

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM2 Q14416 2/20 0.37
SCN10A Q9Y5Y9 2/20 0.36
SCN1A P35498 1/20 0.36
SCN4A P35499 1/20 0.36
KCNH2 Q12809 1/20 0.36
SCN5A Q14524 1/20 0.36
SCN9A Q15858 1/20 0.36
SCN2A Q99250 1/20 0.36
SCN3A Q9NY46 1/20 0.36
SCN8A Q9UQD0 1/20 0.36
ALKBH1 Q13686 1/20 0.35
RORC P51449 1/20 0.34
CHRM5 P08912 6/20 0.34
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33
TNIK Q9UKE5 1/20 0.33
KCNN4 O15554 3/20 0.33
ROCK2 O75116 1/20 0.33
ROCK1 Q13464 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25438155 1.00 GRM2 (0.37) GRM2SCN10ASCN1ASCN4AKCNH2
SCHEMBL29714020 0.84 SCN1A (0.38) GRM2SCN10ASCN1ASCN4AKCNH2
SCHEMBL22470576 0.84 SCN1A (0.38) GRM2SCN10ASCN1ASCN4AKCNH2
SCHEMBL31069731 0.82 SCN1A (0.49) GRM2SCN10ASCN1ASCN4AKCNH2
SCHEMBL25380407 0.82 SCN1A (0.49) GRM2SCN10ASCN1ASCN4AKCNH2
SCHEMBL31069723 0.82 ALKBH1 (0.37) GRM2SCN10ASCN1ASCN4AKCNH2
SCHEMBL31069716 0.82 CACNA2D1 (0.45) GRM2SCN10ASCN1ASCN4AKCNH2
SCHEMBL25380642 0.79 TNIK (0.39) SCN10ASCN1ASCN4AKCNH2SCN5A
SCHEMBL31069732 0.79 TNIK (0.39) SCN10ASCN1ASCN4AKCNH2SCN5A
SCHEMBL31118862 0.74 SCN1A (0.55) GRM2SCN10ASCN1ASCN4AKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118556044-A Fused heterocyclic compound, preparation method thereof and application thereof in medicine 江苏恒瑞医药股份有限公司 2024-08-27 CN disclosed